β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseases

• Main Authors: Xun-Hu Gu (Author), Weichao Li (Author), Heng Li (Author), Xun Guo (Author), Jiang He (Author), Yuyan Liu (Author), Jianping Gong (Author), Yizhou Huang (Author), Bin Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Backgroundβ-blockers have been widely used in patients with extensive cardiovascular disease (CVD) and have provided benefits. However, they are more likely to cause symptomatic bradycardia, hypotension, or glucose metabolism disorders, which may lead to an increased risk of atrial fibrillation (AF)...